Literature DB >> 26680645

Comparison between the triglycerides standardization of routine methods used in Japan and the chromotropic acid reference measurement procedure used by the CDC Lipid Standardization Programme.

Masakazu Nakamura1, Hiroyasu Iso2, Akihiko Kitamura2, Hironori Imano2, Hiroyuki Noda2, Masahiko Kiyama3, Shinichi Sato4, Kazumasa Yamagishi5, Kunihiro Nishimura6, Michikazu Nakai6, Hubert W Vesper7, Tamio Teramoto8, Yoshihiro Miyamoto9.   

Abstract

Background The US Centers for Disease Control and Prevention ensured adequate performance of the routine triglycerides methods used in Japan by a chromotropic acid reference measurement procedure used by the Centers for Disease Control and Prevention lipid standardization programme as a reference point. We examined standardized data to clarify the performance of routine triglycerides methods. Methods The two routine triglycerides methods were the fluorometric method of Kessler and Lederer and the enzymatic method. The methods were standardized using 495 Centers for Disease Control and Prevention reference pools with 98 different concentrations ranging between 0.37 and 5.15 mmol/L in 141 survey runs. The triglycerides criteria for laboratories which perform triglycerides analyses are used: accuracy, as bias ≤5% from the Centers for Disease Control and Prevention reference value and precision, as measured by CV, ≤5%. Results The correlation of the bias of both methods to the Centers for Disease Control and Prevention reference method was: y (%bias) = 0.516 × (Centers for Disease Control and Prevention reference value) -1.292 ( n = 495, R2 = 0.018). Triglycerides bias at medical decision points of 1.13, 1.69 and 2.26 mmol/L was -0.71%, -0.42% and -0.13%, respectively. For the combined precision, the equation y (CV) = -0.398 × (triglycerides value) + 1.797 ( n = 495, R2 = 0.081) was used. Precision was 1.35%, 1.12% and 0.90%, respectively. It was shown that triglycerides measurements at Osaka were stable for 36 years. Conclusions The epidemiologic laboratory in Japan met acceptable accuracy goals for 88.7% of all samples, and met acceptable precision goals for 97.8% of all samples measured through the Centers for Disease Control and Prevention lipid standardization programme and demonstrated stable results for an extended period of time.

Entities:  

Keywords:  Centers for Disease Control and Prevention standardization; GC-IDMS; chromotropic acid reference measurement procedure; enzymatic method; fluorometric method; triglycerides

Mesh:

Substances:

Year:  2016        PMID: 26680645      PMCID: PMC5695560          DOI: 10.1177/0004563215624461

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  31 in total

1.  A SEMIAUTOMATED PROCEDURE FOR THE DETERMINATION OF TRIGLYCERIDES IN SERUM.

Authors:  H B LOFLAND
Journal:  Anal Biochem       Date:  1964-12       Impact factor: 3.365

2.  Reference methods for total cholesterol and total glycerol.

Authors:  L Siekmann
Journal:  Eur J Clin Chem Clin Biochem       Date:  1991-04

3.  Addition of triglyceride to serum for use in quality control and reference.

Authors:  D P Bonderman; G J Proksch; P W Bonderman
Journal:  Clin Chem       Date:  1976-08       Impact factor: 8.327

4.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

5.  Use and interpretation of common statistical tests in method-comparison studies.

Authors:  J O Westgard; M R Hunt
Journal:  Clin Chem       Date:  1973-01       Impact factor: 8.327

6.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

7.  Fasting triglyceride is a significant risk factor for coronary artery disease in middle-aged Japanese men.

Authors:  Hiroki Satoh; Tetsuo Nishino; Kazuo Tomita; Hiroyuki Tsutsui
Journal:  Circ J       Date:  2006-03       Impact factor: 2.993

8.  Preparation of reference sera with desired levels of cholesterol and triglyceride.

Authors:  M Kuchmak; L Taylor; J H Williams
Journal:  Clin Chim Acta       Date:  1981-08-10       Impact factor: 3.786

9.  Serum triglycerides and risk of coronary heart disease among Japanese men and women.

Authors:  H Iso; Y Naito; S Sato; A Kitamura; T Okamura; T Sankai; T Shimamoto; M Iida; Y Komachi
Journal:  Am J Epidemiol       Date:  2001-03-01       Impact factor: 4.897

10.  Determination of glycerol concentrations and glycerol isotopic enrichments in human plasma by gas chromatography/mass spectrometry.

Authors:  M T Ackermans; A F Ruiter; E Endert
Journal:  Anal Biochem       Date:  1998-04-10       Impact factor: 3.365

View more
  3 in total

1.  Leukocyte Count and Risks of Stroke and Coronary Heart Disease: The Circulatory Risk in Communities Study (CIRCS).

Authors:  Jiaqi Li; Hironori Imano; Kazumasa Yamagishi; Mari Tanaka; Renzhe Cui; Isao Muraki; Mitsumasa Umesawa; Mina Hayama-Terada; Tetsuya Ohira; Masahiko Kiyama; Takeo Okada; Tomoko Sankai; Takeshi Tanigawa; Akihiko Kitamura; Hiroyasu Iso
Journal:  J Atheroscler Thromb       Date:  2021-03-21       Impact factor: 4.394

2.  Impacts of demographic and laboratory parameters on key hematological indices in an adult population of southern Taiwan: A cohort study.

Authors:  Ming-Chung Wang; Cih-En Huang; Meng-Hung Lin; Yao-Hsu Yang; Chang-Hsien Lu; Ping-Tsung Chen; Yu-Ying Wu; Hsing-Yi Tsou; Chia-Chen Hsu; Chih-Cheng Chen
Journal:  PLoS One       Date:  2018-08-02       Impact factor: 3.240

3.  Impact of Major Cardiovascular Risk Factors on the Incidence of Cardiovascular Disease among Overweight and Non-Overweight Individuals: The Circulatory Risk in Communities Study (CIRCS).

Authors:  Takumi Matsumura; Tomoko Sankai; Kazumasa Yamagishi; Yasuhiko Kubota; Mina Hayama-Terada; Isao Muraki; Mitsumasa Umesawa; Renzhe Cui; Hironori Imano; Tetsuya Ohira; Akihiko Kitamura; Takeo Okada; Masahiko Kiyama; Hiroyasu Iso
Journal:  J Atheroscler Thromb       Date:  2021-03-16       Impact factor: 4.928

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.